At 1 year the estimated success of treatment was 80.1% with 5% 5-FU, 72.8% for MAL-PDT, and, 83.4% on using imiquimod which has proved the superiority of imiquimod to MAL-PDT in treating sBCC while topical 5-FU was not inferior
Our medical providers will walk you through the process so you know exactly what to expect
Polycystic Ovary Syndrome and Endocrine Disruptors (Bisphenols, Parabens, and Triclosan)-A Systematic Review
R., Ramata-Stunda, A., Rostoks, N., Jirgensons, A., Ta Rs, K., and Jaudzems, K
Common stacks include: GLOW stack: GHK-CU + BPC-157 + TB-500 Anti-aging stack: GHK-CU + CJC-1295 /Ipamorelin Skin stack: GHK-CU + Epithalon When stacking, some researchers reduce individual compound doses by 25-50% from standalone protocols